Working… Menu

A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04470427
Recruitment Status : Active, not recruiting
First Posted : July 14, 2020
Last Update Posted : June 10, 2021
Biomedical Advanced Research and Development Authority
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
ModernaTX, Inc.